- Home
- BLDEW vs ETW Comparison
BLDEW vs ETW Comparison
Compare BLDEW & ETW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDEW
- ETW
- Stock Information
- Founded
- BLDEW 2014
- ETW 2005
- Country
- BLDEW United States
- ETW United States
- Employees
- BLDEW 281
- ETW N/A
- Industry
- BLDEW Transportation Services
- ETW Investment Managers
- Sector
- BLDEW Consumer Discretionary
- ETW Finance
- Exchange
- BLDEW Nasdaq
- ETW Nasdaq
- Market Cap
- BLDEW N/A
- ETW N/A
- IPO Year
- BLDEW N/A
- ETW N/A
- Fundamental
- Price
- BLDEW $0.14
- ETW $7.79
- Analyst Decision
- BLDEW
- ETW
- Analyst Count
- BLDEW 0
- ETW 0
- Target Price
- BLDEW N/A
- ETW N/A
- AVG Volume (30 Days)
- BLDEW 51.0K
- ETW 284.6K
- Earning Date
- BLDEW 03-13-2025
- ETW 01-01-0001
- Dividend Yield
- BLDEW N/A
- ETW 8.61%
- EPS Growth
- BLDEW N/A
- ETW N/A
- EPS
- BLDEW N/A
- ETW N/A
- Revenue
- BLDEW $241,814,000.00
- ETW N/A
- Revenue This Year
- BLDEW N/A
- ETW N/A
- Revenue Next Year
- BLDEW N/A
- ETW N/A
- P/E Ratio
- BLDEW N/A
- ETW N/A
- Revenue Growth
- BLDEW 12.04
- ETW N/A
- 52 Week Low
- BLDEW $0.30
- ETW $6.96
- 52 Week High
- BLDEW $0.36
- ETW $8.49
- Technical
- Relative Strength Index (RSI)
- BLDEW N/A
- ETW 43.20
- Support Level
- BLDEW N/A
- ETW $7.67
- Resistance Level
- BLDEW N/A
- ETW $7.98
- Average True Range (ATR)
- BLDEW 0.00
- ETW 0.28
- MACD
- BLDEW 0.00
- ETW 0.01
- Stochastic Oscillator
- BLDEW 0.00
- ETW 63.24
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.